PHS Seminar: "Surrogate Endpoints for Cancer Clinical Trials: Opportunities and Challenges" by James J. Dignam, PhD
Billings Hospital, Room W229
Abstract: There is continued and growing interest in the adoption of surrogate endpoints (endpoints that can reliably portent treatment efficacy on ultimate clinical outcomes) in cancer therapy…
Want company? Say you're going on Tap2Vibe, then find people to go with.